Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Ainsling Capital Raises $280m For Latest Life Sciences Fund
Private Equity

Ainsling Capital Raises $280m For Latest Life Sciences Fund

by finalternatives.com posted 9months ago 123 views
New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market. read more

In this article